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Aims To test the hypothesis that virtual functional assessment index (vFAI) is related with regional flow parameters
derived by quantitative positron emission tomography (PET) and can be used to assess abnormal vasodilating cap-




vFAI, stress myocardial blood flow (MBF), and myocardial flow reserve (MFR) were assessed in 78 patients (mean
age 62.2 ± 7.7 years) with intermediate pre-test likelihood of coronary artery disease (CAD). Coronary stenoses
>_50% were considered angiographically significant. PET was considered positive for significant CAD, when more
than one contiguous segments showed stress MBF <_2.3 mL/g/min for 15O-water or <1.79 mL/g/min for 13N-ammo-
nia. MFR thresholds were <_2.5 and <_2.0, respectively. vFAI was lower in vessels with abnormal stress MBF
(0.76 ± 0.10 vs. 0.89 ± 0.07, P < 0.001) or MFR (0.80 ± 0.10 vs. 0.89 ± 0.07, P < 0.001). vFAI had an accuracy of 78.6%
and 75% in unmasking abnormal stress MBF and MFR in 15O-water and 82.7% and 71.2% in 13N-ammonia studies,
respectively. Addition of vFAI to anatomical CCTA data increased the ability for predicting abnormal stress MBF
and MFR in 15O-water studies [AUCcctaþ vfai = 0.866, 95% confidence interval (CI) 0.783–0.949; P = 0.013 and
AUCcctaþ vfai = 0.737, 95% CI 0.648–0.825; P = 0.007, respectively]. An incremental value was also demonstrated for
prediction of stress MBF (AUCcctaþ vfai = 0.887, 95% CI 0.799–0.974; P = 0.001) in
13N-ammonia studies. A similar
trend was recorded for MFR (AUCcctaþ vfai = 0.780, 95% CI 0.632–0.929; P = 0.13).
...................................................................................................................................................................................................
Conclusion vFAI identifies accurately the presence of impaired vasodilating capability. In combination with anatomical data,
vFAI enhances the diagnostic performance of CCTA.
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Introduction
Coronary computed tomography angiography (CCTA) is the ref-
erence standard for non-invasive evaluation of coronary anatomy.1
More recently, interrogation of functional significance of coronary
lesions detected by CCTA has also become feasible through com-
putation of computed tomography (CT)-derived fractional flow
reserve (FFRCT).
2 FFRCT has demonstrated adequate accuracy for
detection of haemodynamically significant lesions without add-
itional radiation exposure3 and equivalent clinical outcomes,
quality-of-life and lower costs, compared with usual care over
1-year follow-up.4 However, it has technical limitations5 and in
addition, remote and lengthy core-laboratory analysis is required
for the current version of the most commonly tested software.6
Virtual functional assessment index (vFAI) has been proposed7 as a
computational FFR surrogate to detect flow-limiting coronary
stenoses. This index can also be derived effectively from CCTA
and an initial validation against invasive FFR has demonstrated
good agreement between the two parameters.8
Coronary blood flow is a more comprehensive marker of the
functional status of coronary circulation than pressure-derived
estimates providing integrated assessment both of the epicardial
vessels and the microcirculation, and therefore, constitutes a par-
ameter of great interest for diagnostic and management strat-
egies.9 In the non-invasive setting, quantitative measurement of
myocardial blood flow (MBF) at rest and stress and myocardial
flow reserve (MFR) using positron emission tomography (PET)
provide accurate assessment of functionally significant coronary
artery disease (CAD).10 A number of studies have explored the re-
lationship between FFR, stress MBF, and MFR showing only a mod-
erate correlation between those parameters.11–13 However, there
are no studies testing the ability of CCTA-derived FFR to predict
perfusion changes by PET downstream stenotic vessels. The pur-
pose of the present study was to test the hypothesis that vFAI is
related with regional flow parameters derived by quantitative PET
and it can be used to detect impaired blood flow vasodilating cap-
ability in patients submitted to CCTA.
Methods
Study population
In the context of the FP-7 EVINCI (NCT00979199) and the Horizon
2020 SMARTool (www.smartool.eu) projects, individuals with stable
symptoms and intermediate pre-test probability of CAD who, as per
study protocol, have undergone both CCTA and PET perfusion with
available quantitative data were identified. The time-interval between
PET and CCTA studies was 6 ± 18 days. The characteristics of the study
population, details on imaging procedures and protocols have already
been described elsewhere.14 Based on the selection criteria for the
SMARTool project, only EVINCI studies with a fair to excellent CCTA
image quality were included in the analysis. Accordingly, 21 from the 99
EVINCI patients who have undergone both CCTA and PET were
excluded, as they did not meet the pre-specified standards. The included
patients had at least one vessel free of noise, motion artefacts, or heavy
calcifications and a maximum increment between slices of less or equal to
0.625 mm.
CCTA imaging and processing
The CCTA acquisition protocol (Supplementary data online) has been
described in detail previously.14 Scan quality of the CCTA was classified
as excellent, good, fair, and poor.
3D reconstruction process
The 3D reconstruction was performed using in-house developed algo-
rithms and the reconstruction process was carried out as previously
described.7 It is carried out in seven steps as follows: (i) pre-processing of
the CCTA images with the Frangi Vesselness filter is performed limiting
the region of interest to possible vessel regions; (ii) using a minimum cost
path approach, the 3D centreline of the vessels is then extracted; (iii)
employing a membership function of Hounsfield Units (HU) values and
the distance from the centreline, an estimation of the weight function for
lumen, outer wall, and calcified plaque is made. An extension of the active
contour model estimation for (iv) the lumen and (v) the outer wall seg-
mentation are subsequently implemented; (vi) regarding plaque segmen-
tation, a level set method is applied, taking into account calcified objects
of significant size; (vii) finally, the 3D surfaces for the lumen, outer wall,
and calcified plaques are created. For the purpose of the present study
only main coronary branches were used for analysis. Accordingly, for
right coronary artery (RCA) vessels, segments 1–3 were included in the
reconstruction process, for left anterior descending artery (LAD), seg-
ments 6–8, and for the left circumflex artery (LCx), segments 11 and 13
were included, according to the SYNTAX SCORE mapping.
vFAI calculation
Blood flow simulations were carried out using a finite element commer-
cial software (ANSYSVR CFX 15, Canonsburg, PA, USA). A tetrahedral
mesh was created for each vessel and the Navier–Stokes and continuity
equations were solved. The vFAI calculation process has been described
in detail in Ref.7 Briefly, the aforementioned blood flow simulations are
performed to calculate the ratio of distal to proximal pressure over the
examined segment for volumetric flows in the range from 0 mL/s to
4 mL/s, normalized by the ratio over this range for a completely healthy
arterial segment, offering a measure of haemodynamic significance that is
numerically equivalent to the average of the computed pressure ratio
over this flow range. vFAI computation was performed by a reader with
experience in analysing CCTA images and using the 3D reconstruction
module optimally, who was unaware of the perfusion and hybrid CCTA-
PET results. Specific procedural details are described in vFAI calculation
(Supplementary data online).
PET imaging and data analysis
PET scanning with 15O-water or 13N-ammonia was performed according
to international guidelines as described elsewhere.15 Protocol details are
described in PET imaging (Supplementary data online). CCTA and PET
images were fused to assign each myocardial segment to the pertinent
coronary territory and every coronary stenosis to areas of myocardial
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perfusion using a dedicated workstation (Advantage Workstation 4.4, GE
Healthcare) and the CardIQ Fusion software package (GE Healthcare) as
previously described.16 Accordingly, to define accurately the functional
significance of coronary stenoses, the specific myocardial segments distal
to the pertinent coronary lesions were identified and the respective MBF
averaged. PET flow quantitation and selection of thresholds in flow values
for detection of significant CAD was performed as previously reported.
Specifically, PET studies were considered positive for impaired
coronary blood flow, when more than one contiguous segments showed
stress MBF <_2.3 mL/g/min for 15O-water or <1.79 mL/g/min for
13N-ammonia.15,17 The corresponding MFR thresholds were <_2.5 and
<_2 for 15O-water and 13N-ammonia, respectively.15,17 Analysis of all PET
images was performed by two experienced independent physicians who
were unaware of the patients’ data.
Statistical analysis
Quantitative data are presented as mean values ± SD, while qualita-
tive variables as absolute and relative frequencies. Probability values
are two-sided from the Student’s t-test or the Mann–Whitney U test
for continuous variables, according to the normal or skewed distribu-
tion of the variables. Assessment for normality of data distribution
was evaluated by Kolmogorov–Smirnov test. For multiple groups
comparisons, ANOVA or Kruskal–Wallis test was used. A P-value
<0.05 was considered statistically significant. To assess the relation-
ship between CCTA-vFAI values and PET-derived parameters, the
Pearson’s correlation coefficient was used. The optimal threshold of
vFAI for predicting an attenuated response to pharmacological stress
in PET 15O-water or 13N-ammonia studies was determined using the
Youden index. Subsequently for identifying a single cut-off, potential
statistically significant differences in diagnostic performance between
the latter and individual tracer and PET index (stress MBF or MFR)-
specific thresholds were assessed by comparison of the receiver op-
erator characteristics (ROC) curves with the DeLong method. The
level of agreement between stress MBF or MFR and vFAI was assessed
by Cohen’s j-statistic.
Angiographic stenosis severity was classified as: <30%, 30–49%, 50–70,
and 70–90%. A threshold of a stenosis severity >_50% on CCTA was used
for defining angiographically significant coronary stenosis. When multiple
stenoses were present in the same vessel, the most severe one was used
to assess the CCTA performance for detecting impaired stress MBF or
MFR. Sensitivity and specificity values of CCTA and vFAI for identification
of abnormal hyperaemic response or MFR were calculated. The following
models were constructed and compared using Harrel’s c-statistics:
CCTA (using as cut-off >_50%), vFAI (as dichotomous variable, normal–
abnormal) and vFAIþCCTA (computed by means of logistic regression
model).18 Statistical analyses were performed using the SPSS software
version 20 (Chicago, IL, USA), while MedCalc software version 13
(Ostend, Belgium) was used for the comparison of the areas under the
ROC curves.19
Results
Patient and vessel characteristics
Baseline demographic, clinical, and lesion characteristics of the
study population are summarized in Table 1. By hybrid imaging
analysis, from a total of 234 coronary arteries, in 22 vessels vFAI
was not performed because either of sub-optimal image quality (3
LAD, 4 LCx, and 3 RCA), or having limited contribution to the
perfusion of the corresponding myocardial territory (12 RCA).
From the remaining 212 vessels, in which vFAI was calculated, 61,
39, and 6 coronary arteries had a 30–49% (57.0%), 50–70%
(36.4%), and 70–90% stenosis (5.6%) on CCTA, respectively.
Eighteen vessels with a stenosis >_30% presented multiple lesions
(16.8%). MBF and MFR values were quantitated by 13N-ammonia
for 53 vessels (14 with >_50% stenosis) and by 15O-water for 159
vessels (31 with >_50% stenosis).
Impact of stenosis severity on
quantitative coronary functional
parameters
vFAI values corresponding to lesions >_50% were significantly lower
compared with those of intermediate severity (30–49%) and non-
stenotic lesions (<30%). Similarly, stress MBF and MFR values derived
.................................................................................................
Table 1 Baseline patient characteristics
Patients (n 5 78) N (%)
Age (years) 62.2 ± 7.7
Gender (male) 38 (54)
Symptoms
Typical angina 11 (15)
Atypical angina 42 (60)
Non-anginal chest pain 18 (25)
Risk factors
Arterial hypertension 37 (52)
Dyslipidaemia 43 (61)
Smoking 14 (20)
Family history of CAD 26 (37)
Diabetes mellitus 11 (15)
Obesity 13 (18)
BMI 26.9 ± 3.7
Medications







Calcium antagonists 9 (13)
ASA 53 (75)
Nitrates 9 (13)




Total vessels with stenosis >_50% (vFAI) 45
15O-water 31 (19.5)
13N-ammonia 14 (26.4)
LVEF 54.94 ± 7.05
ACEI, angiotensin-converting-enzyme inhibitor; ARBs, angiotensin II receptor
blockers; ASA, aspirin; BMI, body mass index; CAD, coronary artery disease;
LAD, left anterior descending artery; LCx, left circumflex artery; LVEF, left ven-
tricular ejection fraction; RCA, right coronary artery; vFAI, virtual functional as-
sessment index.
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..from 15O-water PET studies declined significantly downstream sten-
otic coronary arteries as compared to vessels with <30% stenosis.
The same trend was shown for 13N-ammonia studies even if the dif-
ferences did not reach statistical significance (Table 2).
Relationship between vFAI and PET
parameters
Figure 1 demonstrates the relationship between vFAI and PET-
derived indices. vFAI was positively correlated with stress MBF
(R = 0.49, P < 0.001 and R = 0.53, P = 0.001) for 15O-water and
13N-ammonia-based measurements, respectively (Figure 1A and B).
A positive correlation was also demonstrated between vFAI and
MFR (R = 0.41, P < 0.001 and R = 0.39, P = 0.004) for 15O-water and
13N-ammonia-based measurements, respectively (Figure 1C and D).
In analysis of all 212 vessels, vFAI was lower in vessels with abnor-
mal stress MBF (median 0.79, P25–P75: 0.68–0.83 vs. median 0.90,
P25–P75 0.86–0.93, P < 0.001, Figure 2A). Similarly, vFAI was lower in
vessels with abnormal MFR (median 0.82, P25–P75: 0.76–0.89 vs.
0.91, P25–P75: 0.86–0.94, P < 0.001, Figure 2B).
Performance of vFAI for predicting
reduced hyperaemic response or MFR
For 15O-water PET studies, a vFAI threshold <_0.8 [AUC: 0.856,
95% confidence interval (CI) 0.775–0.938; P < 0.001] had a per-
vessel sensitivity and specificity, of 77.8% and 90.9%, respectively,
for predicting a stress MBF <_2.3 (Figure 3A). For identifying an
MFR <_2.5, the corresponding values for a vFAI threshold <_0.86
(AUC: 0.796, 95% CI 0.724–0.868; P < 0.001) were 66.7% and
79%, respectively (Figure 3B). A threshold of <_0.8 had sensitivity
84% and specificity 91% (AUC 0.899, 95% CI 0.836–0.961;
.................................................................................................
Table 2 Impact of stenosis severity on quantitative
coronary functional parameters
Stenosis severity P-value
15O-water <30% (n = 81) 30–50% (n = 47)>50% (n = 31)
vFAIa 0.91 ± 0.06 0.84 ± 0.09 0.78 ± 0.12 <0.001
Stress MBF 3.66 ± 0.90b,c 3.08 ± 0.98b 2.55 ± 1.25c <0.001
MFRd 3.25 ± 1.04 2.70 ± 0.79 2.12 ± 0.72 <0.001
13N-ammonia<30% (n = 25) 30–50% (n = 14)>50% (n = 14)
vFAI 0.92 ± 0.05e,f 0.84 ± 0.06f 0.81 ± 0.07e <0.001
Stress MBF 2.38 ± 0.49 2.27 ± 0.57 1.99 ± 0.68 0.12
MFR 2.70 ± 0.80 2.56 ± 0.63 2.11 ± 0.80 0.08
Both tracers <30% (n = 106)30–50% (n = 61)>50% (n = 45)
vFAIg 0.91 ± 0.06 0.84 ± 0.08 0.79 ± 0.10 <0.001
MFR, myocardial flow reserve; vFAI, virtual functional assessment index.
aP < 0.05 for all between group comparisons.
b,cP < 0.05 for between group comparisons.
dP < 0.05 for all between group comparisons.
e,fP < 0.05 for between group comparisons.
gP < 0.05 for all between group comparisons.
Figure 1 Scatterplots showing Pearson’s correlation between vFAI and 15O-water PET stress MBF (A) and MFR (C), as well as between vFAI and
13N-ammonia stress MBF (B) and MFR, respectively (D). All quantitative 15O-water and 13N-ammonia indices associated significantly with vFAI.
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.P < 0.001) for predicting concordant impairment of both stress
MBF and MFR. For 13N-ammonia, the optimal threshold of vFAI to
detect a stress MBF <1.79 was <_0.85 (AUC: 0.905, 95% CI 0.825–
0.986; P < 0.001); per-vessel sensitivity 100%, specificity, 76.9%.
The same threshold could predict an abnormal MFR <2 with sen-
sitivity 76.9% and specificity 69.2% (AUC: 0.767, 95% CI 0.635–
0.899; P = 0.004) (Figure 3C and D). A vFAI <_0.85 (AUC 0.856,
95% CI 0.756–0.956; P = 0.001) had sensitivity 100% and specificity
Figure 2 vFAI in normal vs. abnormal stress MBF and MFR territories. vFAI was significantly lower in vessels with abnormal stress MBF (A) or MFR (B).
Figure 3 ROC curves of the diagnostic performance of vFAI for detecting attenuated stress MBF <_2.3 (A) or MFR <_2.5 (B) for 15O-water PET
studies, and stress MBF <1.79 (C) or MFR <2 (D) for 13N-ammonia studies.
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71.4% for predicting concordant impairment of both stress MBF
and MFR.
Considering the propinquity of these cut-off values, the diagnostic
accuracy of a single vFAI threshold 0.85 was tested against the tracer-
specific individual threshold values. No statistically significant differen-
ces in diagnostic performance were identified and for practical
purposes, a single threshold of <_0.85 was used for subsequent ana-
lysis. vFAI had an accuracy of 78.6% and 75% in unmasking abnormal
stress MBF and MFR in 15O-water and 82.7% and 71.2% in 13N-am-
monia studies, respectively. Details of diagnostic characteristics of
vFAI for predicting impaired coronary vasodilating response with a
cut-off value <_0.85 vs. the optimal cut-offs are presented in Table 3.
Agreement between vFAI and PET measurements is shown in
Supplementary data online, Table S1.
Comparison of CCTA and vFAI for
predicting reduced hyperaemic response
or MFR
The rates of territories with normal vs. abnormal stress MBF or MFR
in relation to stenosis severity and vFAI, for the total analysed vessels
are presented in Figure 4.
Sensitivity and specificity of CCTA for detecting an abnormal stress
MBF in 15O-water studies, using as threshold a stenosis severity >_50%
were 63% and 89.4% whilst, the corresponding values for predicting
an attenuated MFR were 35.2% and 88.6%, respectively. Sensitivity and
specificity of CCTA for detecting an abnormal stress MBF in 13N-am-
monia studies were 42.9% and 73.8% whilst, the corresponding values
for predicting an attenuated MFR were 53.3% and 78%, respectively.
The performance of vFAI for predicting abnormal stress MBF in
15O-water studies was similar to that of CCTA (AUCvfai = 0.798,
95% CI 0.703–0.892 vs. AUCccta = 0.762, 95% CI 0.648–0.876;
P = 0.54, respectively). However, the addition of vFAI variable to
CCTA, increased the predictive ability of the anatomy-based model
significantly (AUCcctaþ vfai = 0.866, 95% CI 0.783–0.949; P = 0.013).
vFAI performed better than CCTA for predicting abnormal MFR
(AUCvfai = 0.720, 95% CI 0.631–0.808 and AUCccta = 0.619, 95% CI
0.523–0.715; P = 0.02). Moreover, the addition of vFAI variable to
CCTA increased the predictive capacity of the anatomy-based model
significantly (AUCcctaþ vfai = 0.737, 95% CI 0.648–0.825; P = 0.007).
vFAI performed better than CCTA for predicting abnormal stress
MBF in 13N-ammonia studies (AUCvfai = 0.885, 95% CI 0.796–0.973
and AUCccta = 0.628, 0.444–0.813; P = 0.002). Moreover, the addition
of vFAI variable to CCTA increased the predictive capacity of the
model significantly (AUCcctaþ vfai = 0.887, 95% CI 0.799–0.974;
P = 0.001). There was no significant difference between the model
based on CCTA and the model based on vFAI for prediction of ab-
normal MFR (AUCvfai = 0.731, 95% CI 0.572–0.889 and
AUCccta = 0.679, 95% CI 0.499–0.860; P = 0.58). The addition of vFAI
to the model based on CCTA demonstrated the same trend as in the
15O-water studies, even if it did not reach statistical significance
(AUCcctaþ vfai = 0.780, 95% CI 0.632–0.929; P = 0.13).
An example of a patient with multiple vessel CAD, abnormal vFAI
and MFR in the corresponding coronary territories is shown in
Figure 5.
Discussion
Our main results can be summarized as follows: vFAI (i) can be read-
ily computed from standard CCTA datasets, (ii) correlates modestly
with stress MBF and MFR, (iii) performs well in identifying coronary
lesions with downstream impairment of stress MBF or MFR, and (iv)
in combination with anatomical data enhances the diagnostic per-
formance of CCTA.
Stenosis severity vs. functional indices
Our study is the first to test the relationship between CCTA stenosis
severity, CCTA-based estimates of FFR and specific MBF calculation.
We demonstrated that vFAI was lower in vessels with stenotic
lesions compared with those without stenosis and those vessels with
lesions >_50% had lower vFAI values compared with those with 30–
49% stenosis. PET measurements demonstrated a similar pattern of
impaired coronary vasodilating capability in relation to stenosis sever-
ity. In 15O-water PET studies, the decline of stress MBF and MFR in
stenotic coronary arteries compared with vessels with <30% stenosis
was more significant than in 13N-ammonia studies. This difference
could be explained by the small number of vessels with higher sten-
osis grade (>70%) in the present series. Differences between tracers
in terms of extraction fraction and modelling approaches for perfu-
sion quantification may have increased the accuracy of 15O-water
based measurements in this population.
Pressure-based measurements vs.
quantitative myocardial perfusion
Pressure-derived measures of CAD haemodynamic significance (i.e.
FFR and FFRCT) can only give an indirect assessment of coronary
flow capacity, showing a frequent discrepancy with MFR.20–22 In
keeping with these observations, we have demonstrated that al-
though vFAI was significantly lower in vessels with abnormal stress
MBF or MFR, overall, there was a rather weak to modest correlation
between vFAI and these two parameters and a poor to fair
.................................................................................................
Table 3 Diagnostic performance of vFAI with a cut-








Sensitivity 77.8 81.5 0.0519
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..agreement, with j values ranging from 0.38 to 0.63. Possible explana-
tions are either the generalizations used for computation of vFAI (i.e.
rest and stress coronary flow equalled to 1 mL/s and 3 mL/s, respect-
ively) or the physiological and technical determinants of absolute
flow and flow reserve measurements by PET.21 Like FFR, vFAI can be
reduced in cases of epicardial disease, but MFR can be preserved, if
there is an intact vasodilator response.20 Conversely, impaired MFR
with a normal vFAI may be the result of microvascular dysfunction
alone or in combination with an anatomically unobstructed coronary
artery. In our study, impaired stress MBF or MFR was present in
10.2% and 24.7%, of vessels with anatomical stenosis <50%, respect-
ively. Finally, since only main coronary branches were considered for
the analysis, the possible confounding role on myocardial perfusion
of coronary lesions located in minor-branches cannot be excluded as
a cause of the rather modest concordance between vFAI and PET
measurements.
Figure 5 A 74-year-old man with typical angina and evidence of triple vessel CAD with 50–70% stenoses in the distal LAD, second obtuse marginal
branch, and proximal RCA at CCTA. Hybrid PET/CCTA imaging with 13N-ammonia showed impaired coronary flow capacity in all territories co-
localized with the stenosed coronary vessels (upper panels). vFAI was also reduced in all three coronary vessels (lower panels). The middle panel
depicts the pressure distribution for a flow of 3 mL/s, along with the final Pd/Pa equation for each vessel.
Figure 4 Rates of territories with normal vs. abnormal stress MBF or MFR in relation to stenosis severity and vFAI.
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Prediction of attenuated hyperaemic
response or MFR
We found that vFAI performs well in identifying coronary lesions
with downstream impairment of stress MBF or MFR. The present
study is the first to demonstrate the value of CCTA-based estimates
of FFR in predicting coronary flow capacity on PET imaging, adding
also incremental value over CCTA anatomical data. Our threshold is
different to that of FFRCT, since there are important methodological
differences between assessment of the latter and vFAi, which in con-
trast to FFRCT reflects only vessel geometry-related changes, without
taking into account alterations at the microcirculation level or vascu-
lar resistance and their influence in coronary flow during hyperaemia.
Moreover, the optimal threshold of vFAI for detecting impaired cor-
onary blood flow vasodilating capability by PET is somewhat higher
than that previously reported by our group (<_0.82) using FFR as the
gold standard,8 probably as a result of intrinsic differences between
the two gold-standards for evaluation of the functional significance of
a coronary lesion.
Clinical implications
The development of a CCTA-based index, which could detect reli-
ably the functional significance of a coronary lesion in the range of
30–90% has become of paramount importance as it will allow a com-
plete anatomical-functional characterization of CAD burden by a sin-
gle investigation, possibly reducing the downstream inappropriate
referral to invasive coronary angiography.23 In this context, vFAI is a
validated index of CAD haemodynamic significance, derived from the
application of computational flow dynamics to standard CCTA data-
sets, without need for extra radiation exposure. Its main advantage is
the evidently shorter required computational time to obtain the
results of each case.8 As reported recently, the mean analysis time
required for each of the assessed arteries was 25 ± 10 min, with an
average 3D reconstruction time of around 3 min.8 Furthermore, in
contrast to FFRCT, which requires core-laboratory analysis, vFAI can
be directly calculated from a simple personal computer. Interestingly,
while CT-based FFR has already been shown to mimic the results of
invasive FFR,24–26 a validation against PET-derived absolute MBF
measurements as integrated measures of global coronary fluid dy-
namics, has never been performed. This aspect is of particular rele-
vance, since vFAI, obtained after the 3D modelling of coronary plaque
burden, may only simulate the haemodynamic impact of epicardial
atherosclerosis, disregarding the possible impact of underlying micro-
vascular dysfunction or vascular resistance. Despite these intrinsic
methodological particularities, our results indicate that vFAI might be
an appropriate tool for interrogating the functional significance of a
coronary stenosis at CCTA and they could also suggest a possible
role of vFAI as a gatekeeper to invasive coronary angiography.
Limitations
The results of the present study should be interpreted by taking into
account its rather modest sample size and small number of vessels
with stenosis severity >70%. Therefore, we have performed only a
per-vessel evaluation of CCTA and corresponding PET data analysis.
On the other hand, we have studied only patients with intermediate
likelihood of CAD and followed a hybrid imaging-based approach of
CCTA and PET datasets achieving optimal co-localization of each
coronary artery with the pertinent myocardial territory, thus avoiding
any incorrect assignment of vFAI and MBF data. vFAI was calculated
only in the major coronary segments (i.e. 1–3, 6–8, and 11 and 13, in
accordance with the SYNTAX SCORE mapping). We have excluded
a number of patients from the initial cohort, because of significant
motion or calcification in CCTA, factors that hamper image quality
and vFAI assessment; however, this is within the range reported pre-
viously.27 In our study, the degree of anatomic stenosis was derived
from CCTA and not from coronary angiography, which is the gold
standard for narrowing assessment. Nonetheless, the excellent ac-
curacy of CCTA in quantifying CAD severity has already been dem-
onstrated, making this non-invasive technique of particular value in
the evaluation of patients with an intermediate pre-test probability of
CAD.14 The fact that in patients with multiple significant coronary
stenoses in series only the most severe lesion was used for testing
CCTA performance might have added a possible limitation to data
analysis. However, since only a minor proportion of vessels (6%) had
lesions greater than 50% and multiple stenoses, it is rather unlikely
that they could have affected significantly our results. We acknow-
ledge that from the current dataset, we cannot identify on an individ-
ual basis, patients who will not need further functional testing.
However, this was not the aim of the current study and needs to be
assessed in larger prospective multicentre studies.
Conclusions
Computation of vFAI from CCTA datasets is feasible and is signifi-
cantly correlated with PET measured stress MBF and MFR. vFAI
defines with reasonable accuracy the presence of haemodynamically
significant CAD, likely representing a valid additional tool for compre-
hensive anatomical-functional characterization of CAD by CCTA.
Supplementary data
Supplementary data are available at European Heart Journal - Cardiovascular
Imaging online.
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